FLONASE

Compare FLONASE  to:
Compare
Compare

Generic Name for FLONASE

Fluticasone propionate 50micrograms/spray; aqueous nasal spray.

Legal Classification:

Rx

Pharmacological Class for FLONASE

Steroid.

Manufacturer of FLONASE

GlaxoSmithKline Pharmaceuticals

Indications for FLONASE

Seasonal and perennial allergic and nonallergic rhinitis.

Adult dose for FLONASE

Initially 2 sprays in each nostril once daily or 1 spray in each nostril twice daily (AM and PM). Maintenance: may reduce to 1 spray in each nostril daily. Seasonal allergic rhinitis: 2 sprays in each nostril once daily as needed may suffice.

Children's dosing for FLONASE

<4yrs: not recommended. ≥4yrs: initially 1 spray in each nostril once daily; may increase to 2 sprays in each nostril once daily. Maintenance: 1 spray in each nostril once daily; max 2 sprays in each nostril daily.

Precautions for FLONASE

Maintain regular regimen. Respiratory tract tuberculosis. Infections (eg, ocular herpes simplex). If exposed to measles or chickenpox, consider anti-infective prophylactic therapy. If adrenal insufficiency exists following systemic corticosteroid therapy, replacement with topical corticosteroids may exacerbate symptoms of adrenal insufficiency (eg, depression). Monitor for growth suppression in children. Monitor for hypercorticism and HPA axis suppression (if occur discontinue gradually), and candida infection or other nasal mucosal changes. Avoid eyes. Pregnancy (Cat.C). Nursing mothers.

Interactions for FLONASE

Avoid ritonavir. Caution with potent CYP3A4 inhibitors (eg, ketoconazole).

Adverse Reactions for FLONASE

Headache, pharyngitis, epistaxis, nasal burning, asthma symptoms, GI upset, cough, reduced growth velocity in children.

How is FLONASE supplied?

Spray—16g (120 sprays)

Related Disease:

Rhinitis~nasal preparations

Related Resources

Exel/Exelint infusion set needles recalled

January 26, 2010

FDA notified healthcare professionals of a Class I recall of Exel/Exelint Huber needles, Exel/Exelint Huber Infusion Sets, and Exel/Exelint "Securetouch+" Safety Huber Infusion Sets due to 'coring,' the cutting or dislodging of silicone cores or slivers from the ports into which they are inserted).

Astepro nasal spray 0.15% approved for nasal allergy symptoms

September 02, 2009

The FDA has approved Astepro (azelastine HCl nasal spray, from Meda) 0.15%, a nasal antihistamine, for the relief of symptoms associated with seasonal and perennial allergic rhinitis in patients ≥12 years of age.

Phase 2 study of budesonide/azelastine nasal spray for seasonal allergic rhinitis

March 16, 2009

CyDex Pharmaceuticals announced the presentation of Phase 2 clinical trial results of its Captisol-Enabled budesonide/azelastine nasal spray (CDX-313) for seasonal allergic rhinitis (SAR).

Afrin PureSea nasal rinse available

March 03, 2009

Schering-Plough has launched Afrin PureSea Hydrating Nasal Rinse, a product used to cleanse nasal and sinus passages of mucus, pollutants and irritants.

Astepro available for seasonal allergic rhinitis

February 19, 2009

Astepro nasal spray (azelastine HCl, from Meda) is now available at pharmacies.